Novavax preps to meet global demand, plans capacity for 2B Covid vaccine doses
With three Covid-19 vaccines now authorized by the FDA, focus is now turning to manufacturing capacity. As Novavax prepares to add its vaccine to the mix, it is gearing up to meet global demand with the projected capability of producing about 2 billion vaccine doses by the middle of this year.
Read more...